IMIDAZOTHIADIAZOLE AND IMIDAZOPYRAZINE DERIVATIVES AS PROTEASE ACTIVATED RECEPTOR 4 (PAR4) INHIBITORS FOR TREATING PLATELET AGGREGATION
申请人:Bristol-Myers Squibb Company
公开号:EP3243826A1
公开(公告)日:2017-11-15
The present invention provides thiazole compounds of Formula I
wherein W, Y, R0, R2, R4, R5, R6, R7, X1, X2, X3 and X4 are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.
本发明提供了式 I 的噻唑化合物
其中 W、Y、R0、R2、R4、R5、R6、R7、X1、X2、X3 和 X4 如本文所定义,或其立体异构体、同系物、药学上可接受的盐或溶液形式,其中所有变量如本文所定义。这些化合物是血小板聚集抑制剂,因此可用作治疗或预防血栓栓塞性疾病的药物。